FINN Partners and Hyderus Unite for Global Health Communications and Policy Practice
Move enables FINN to address pressing health priorities in developed and developing nations and expands Hyderus global service capabilities and client offerings and Hyderus co-founders Mark Chataway and Christopher Nial join FINN global health leaders team.
Global independent marketing and communications agency FINN Partners has announced that Hyderus, an international health-focused communications and policy firm, is joining FINN. Co-founders Mark Chataway and Christopher Nial will lead FINN's Global Health Practice and co-lead its EMEA Public Health Group. Hyderus is known for its global work in public health, health policy strategy, drug development and marketing communications, risk perception and crisis management.
The agency will now be branded "Hyderus, a FINN Partners Company." The merger increases FINN's total staff to more than 1,400 employees, with more than 275 professionals worldwide dedicated to the health sector.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
